-
Captopril
Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP Captopril Hypertension USP/EP √ √ -
Bictegravir 1611493-60-7
Zita reAPI Indication Innovator Patent Expiry Date (The US) Bictegravir 1611493-60-7 Hutachiona hweHIV-1 Gilead Sciences Zvita 19, 2033 -
Baloxavir Marboxil 1985606-14-1
Zita reAPI Indication Innovator Patent Expiry Date (The US) Baloxavir Marboxil 1985606-14-1 Furuwenza Shionogi & Roche Sep.21,2031 -
Agomelatine
Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP Agomelatine Kuora mwoyo Mumba √ -
Apixaban
Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP Apixaban VTE Mumba -
Atorvastatin Calcium
Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP Atorvastatin Calcium Hypercholesterolemia Mumba/CEP 29057 √ CEP 2015-034